Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease

Alzheimer's disease (AD) and ageing are associated with impaired learning and memory, and recent findings point toward modulating chromatin remodeling through histone acetylation as a promising therapeutic strategy. Here we report that systemic administration of the HDAC inhibitor 4‐phenylbutyrate (PBA) reinstated fear learning in the Tg2576 mouse model of AD. Tg2576 mice develop age‐dependent amyloid pathology and cognitive decline that closely mimics disease progression in humans. Memory reinstatement by PBA was observed independently of the disease stage: both in 6‐month‐old Tg2576 mice, at the onset of the first symptoms, but also in aged, 12‐ to 16‐month‐old mice, when amyloid plaque deposition and major synaptic loss has occurred. Reversal of learning deficits was associated to a PBA‐induced clearance of intraneuronal Aβ accumulation, which was accompanied by mitigation of endoplasmic reticulum (ER) stress, and to restoration of dendritic spine densities of hippocampal CA1 pyramidal neurons to control levels. Furthermore, the expression of plasticity‐related proteins such as the NMDA receptor subunit NR2B and the synaptic scaffold SAP102 was significantly increased by PBA. Our data suggest that the beneficial effects of PBA in memory are mediated both via its chemical chaperone‐like activity and via the transcriptional activation of a cluster of proteins required for the induction of synaptic plasticity and structural remodeling. © 2010 Wiley Periodicals, Inc.

[1]  Lennart Opitz,et al.  Altered Histone Acetylation Is Associated with Age-Dependent Memory Impairment in Mice , 2010, Science.

[2]  Courtney A Miller,et al.  Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease , 2010, Neuropsychopharmacology.

[3]  R. Nicoll,et al.  The role of SAP97 in synaptic glutamate receptor dynamics , 2010, Proceedings of the National Academy of Sciences.

[4]  T. Bayer,et al.  Histone Deacetylase Inhibitor Valproic Acid Inhibits Cancer Cell Proliferation via Down-regulation of the Alzheimer Amyloid Precursor Protein* , 2010, The Journal of Biological Chemistry.

[5]  E. Marcello,et al.  An Arginine Stretch Limits ADAM10 Exit from the Endoplasmic Reticulum* , 2010, The Journal of Biological Chemistry.

[6]  O. Arancio,et al.  Reversal of long-term dendritic spine alterations in Alzheimer disease models , 2009, Proceedings of the National Academy of Sciences.

[7]  T. Ma,et al.  Synaptic Activity Reduces Intraneuronal Aβ, Promotes APP Transport to Synapses, and Protects against Aβ-Related Synaptic Alterations , 2009, The Journal of Neuroscience.

[8]  S. Haggarty,et al.  HDAC2 negatively regulates memory formation and synaptic plasticity , 2009, Nature.

[9]  Amy S. Lee,et al.  Transcriptional induction of GRP78/BiP by histone deacetylase inhibitors and resistance to histone deacetylase inhibitor–induced apoptosis , 2009, Molecular Cancer Therapeutics.

[10]  A. García-Osta,et al.  Phenylbutyrate Ameliorates Cognitive Deficit and Reduces Tau Pathology in an Alzheimer's Disease Mouse Model , 2009, Neuropsychopharmacology.

[11]  R. Nicoll,et al.  Differential trafficking of AMPA and NMDA receptors by SAP102 and PSD-95 underlies synapse development , 2008, Proceedings of the National Academy of Sciences.

[12]  Dominique Muller,et al.  LTP Promotes a Selective Long-Term Stabilization and Clustering of Dendritic Spines , 2008, PLoS biology.

[13]  Kim N. Green,et al.  Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.

[14]  C. Almeida,et al.  Internalized Antibodies to the Aβ Domain of APP Reduce Neuronal Aβ and Protect against Synaptic Alterations*♦ , 2007, Journal of Biological Chemistry.

[15]  Joel M Stein,et al.  Histone Deacetylase Inhibitors Enhance Memory and Synaptic Plasticity via CREB: CBP-Dependent Transcriptional Activation , 2007, The Journal of Neuroscience.

[16]  Y. Suh,et al.  Swedish amyloid precursor protein mutation increases phosphorylation of eIF2α in vitro and in vivo , 2007, Journal of neuroscience research.

[17]  Li-Huei Tsai,et al.  Recovery of learning and memory is associated with chromatin remodelling , 2007, Nature.

[18]  Toshiharu Suzuki,et al.  Endoplasmic reticulum chaperones inhibit the production of amyloid-β peptides , 2007 .

[19]  Bernardo L Sabatini,et al.  Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.

[20]  L. Maffei,et al.  Developmental Downregulation of Histone Posttranslational Modifications Regulates Visual Cortical Plasticity , 2007, Neuron.

[21]  E. Yilmaz,et al.  Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes , 2006, Science.

[22]  T. Uehara,et al.  Suppressive effects of 4‐phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress , 2006, Journal of neurochemistry.

[23]  Mark Bowlby,et al.  Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Comery,et al.  Acute γ-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[25]  S. Ackerman,et al.  Protein accumulation and neurodegeneration in the woozy mutant mouse is caused by disruption of SIL1, a cochaperone of BiP , 2005, Nature Genetics.

[26]  N. Sonenberg,et al.  Translational control in stress and apoptosis , 2005, Nature Reviews Molecular Cell Biology.

[27]  Dominic M. Walsh,et al.  Certain Inhibitors of Synthetic Amyloid β-Peptide (Aβ) Fibrillogenesis Block Oligomerization of Natural Aβ and Thereby Rescue Long-Term Potentiation , 2005, The Journal of Neuroscience.

[28]  J. D. McGaugh,et al.  Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice , 2005, Neuron.

[29]  O. Vitolo,et al.  Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. , 2004, The Journal of clinical investigation.

[30]  D. Molfese,et al.  Regulation of Histone Acetylation during Memory Formation in the Hippocampus* , 2004, Journal of Biological Chemistry.

[31]  E. Kandel,et al.  Chromatin Acetylation, Memory, and LTP Are Impaired in CBP+/− Mice A Model for the Cognitive Deficit in Rubinstein-Taybi Syndrome and Its Amelioration , 2004, Neuron.

[32]  D. Selkoe,et al.  Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. , 2004, Protein and peptide letters.

[33]  C. Almeida,et al.  Oligomerization of Alzheimer's β-Amyloid within Processes and Synapses of Cultured Neurons and Brain , 2004, The Journal of Neuroscience.

[34]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[35]  R. Petralia,et al.  NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex , 2003, Nature Cell Biology.

[36]  Akihiko Takashima,et al.  Chaperones increase association of tau protein with microtubules , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Chang,et al.  Phosphorylation of eukaryotic initiation factor-2&agr; (eIF2&agr;) is associated with neuronal degeneration in Alzheimer's disease , 2002, Neuroreport.

[38]  D. Perlmutter Chemical Chaperones: A Pharmacological Strategy for Disorders of Protein Folding and Trafficking , 2002, Pediatric Research.

[39]  P. Greengard,et al.  Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. , 2002, The American journal of pathology.

[40]  Xin Wu,et al.  Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model , 2002, Nature Neuroscience.

[41]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[42]  T. Freund,et al.  Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells , 2001, Neuroscience.

[43]  R. Nicoll,et al.  PSD-95 involvement in maturation of excitatory synapses. , 2000, Science.

[44]  K. J. Murphy,et al.  Transient spine density increases in the mid-molecular layer of hippocampal dentate gyrus accompany consolidation of a spatial learning task in the rodent , 2000, Neuroscience.

[45]  M. Sheng,et al.  alpha-actinin-2 in rat striatum: localization and interaction with NMDA glutamate receptor subunits. , 2000, Brain research. Molecular brain research.

[46]  J. Goodhouse,et al.  Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice , 2000, Nature Neuroscience.

[47]  J. Hell,et al.  A Developmental Change in NMDA Receptor-Associated Proteins at Hippocampal Synapses , 2000, The Journal of Neuroscience.

[48]  P. Zeitlin,et al.  Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR. , 2000, American journal of physiology. Cell physiology.

[49]  Y. Itoyama,et al.  Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response , 1999, Nature Cell Biology.

[50]  E. Shimizu,et al.  Genetic enhancement of learning and memory in mice , 1999, Nature.

[51]  R. Turner,et al.  The Chaperone BiP/GRP78 Binds to Amyloid Precursor Protein and Decreases Aβ40 and Aβ42 Secretion* , 1998, The Journal of Biological Chemistry.

[52]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[53]  D. Sparks,et al.  Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease. , 1996, Dementia.

[54]  Joseph E LeDoux,et al.  Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. , 1992, Behavioral neuroscience.

[55]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[56]  T. Tuñón,et al.  Neuronal alterations in patients with dementia: a Golgi study on biopsy samples , 1990, Neuroscience Letters.

[57]  J. Sambrook,et al.  The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins , 1988, Nature.

[58]  Edmund M. Glaser,et al.  Analysis of thick brain sections by obverse—Reverse computer microscopy: Application of a new, high clarity Golgi—Nissl stain , 1981, Journal of Neuroscience Methods.

[59]  O. Arancio,et al.  Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[60]  T. Bredy,et al.  The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fear. , 2008, Learning & memory.

[61]  Toshiharu Suzuki,et al.  Endoplasmic reticulum chaperones inhibit the production of amyloid-beta peptides. , 2007, The Biochemical journal.

[62]  C. Almeida,et al.  Internalized antibodies to the Abeta domain of APP reduce neuronal Abeta and protect against synaptic alterations. , 2007, The Journal of biological chemistry.

[63]  F. LaFerla,et al.  Intracellular amyloid-beta in Alzheimer's disease. , 2007, Nature reviews. Neuroscience.

[64]  T. Comery,et al.  Acute gamma-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[65]  D. Selkoe,et al.  Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[66]  R. Turner,et al.  The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Abeta40 and Abeta42 secretion. , 1998, The Journal of biological chemistry.

[67]  S. Brusilow,et al.  Urea cycle disorders: diagnosis, pathophysiology, and therapy. , 1996, Advances in pediatrics.

[68]  E. Kandel,et al.  Structural changes accompanying memory storage. , 1993, Annual review of physiology.